SB Informer
Monday, July 10, 2006; 07:40 AM
Escalon Medical Corp.
(Nasdaq: ESMC) today announced, for the third year in a row, its inclusion in
Fortune Small Business' top 100 fastest-growing small public companies in
America. Fortune Small Business, in conjunction with Zacks Investment
Research, evaluated publicly-traded companies with revenues of less than
Escalon Medical Corp.'s CEO, Richard J. DePiano commented, "We are pleased
to be ranked in this well-regarded list for three consecutive years. This
recognition reflects the efforts of a well-focused team and our continued
commitment to being a leading resource to our customers." In addition to this
recognition by FSB, Escalon was recognized by Forbes Magazine as one of its
"200 Best Small Companies" in
The FSB 100 list appears in the July/August issue of Fortune Small Business and is available at FSB.com.
Founded in 1987, Escalon develops markets and distributes ophthalmic
diagnostic, surgical and pharmaceutical products as well as vascular access
devices. Drew, which operates as a separate business unit, provides
instrumentation and consumables for the diagnosis and monitoring of medical
disorders in the areas of diabetes, cardiovascular diseases and hematology, as
well as veterinary hematology and blood chemistry. Escalon seeks to utilize
strategic partnerships to help finance its development programs and is also
seeking acquisitions to further diversify its product line to achieve critical
mass in sales and take better advantage of the Escalon's distribution
capabilities. Escalon has headquarters in Wayne, Pennsylvania and
manufacturing operations in Long Island, New York, New